Havelhoehe Research Institute, Kladower Damm 221, 14089 Berlin, Germany.
BMC Fam Pract. 2009 Dec 10;10:78. doi: 10.1186/1471-2296-10-78.
The management of hypertension is a key challenge in modern health systems. This study aimed to investigate hypertension treatment strategies among physicians specialized in complementary and alternative medicine (CAM) in Germany by analysing prescribing patterns and comparing these to the current treatment guidelines issued by the German Hypertension Society.
In this prospective, multicentre observational study, which included 25 primary care physicians specialized in CAM treatment, prescriptions and diagnoses were analysed for each consecutive hypertensive patient using routine electronic data. Data analysis was performed using univariate statistical tests (Chi square test, Cochran-Armitage trend test). Multiple logistic regression was used to determine factors associated with antihypertensive medication.
In the year 2005, 1320 patients with 3278 prescriptions were included (mean age = 64.2 years (SD = 14.5), 63.5% women). Most patients were treated with conventional antihypertensive monotherapies (n = 838, 63.5%). Beta-blockers were the most commonly prescribed monotherapy (30.7%), followed by ACE inhibitors (24.0%). Combination treatment usually consisted of two antihypertensive drugs administered either as separate agents or as a coformulation. The most common combination was a diuretic plus an ACE inhibitor (31.2% of dual therapies). Patient gender, age, and comorbidities significantly influenced which treatment was prescribed. 187 patients (14.2%) received one or more CAM remedies, most of which were administered in addition to classic monotherapies (n = 104). Men (OR = 0.66; 95% CI: 0.54-0.80) and patients with diabetes (OR = 0.55; 95% CI: 0.42-0.0.73), hypercholesterolaemia (OR = 0.59; 95% CI: 0.47-0.75), obesity (OR = 0.74; 95% CI: 0.57-0.97), stroke (OR = 0.54; 95% CI: 0.40-0.74), or prior myocardial infarction (OR = 0.37; 95% CI: 0.17-0.81) were less likely to receive CAM treatment.
The large majority of antihypertensive treatments prescribed by CAM physicians in the present study complied with the current German Hypertension Society treatment guidelines. Deviations from the guidelines were observed in one of every seven patients receiving some form of CAM treatment.
高血压的管理是现代卫生系统的一个主要挑战。本研究旨在通过分析处方模式,调查德国专门从事补充和替代医学(CAM)的医生的高血压治疗策略,并将这些与德国高血压学会发布的当前治疗指南进行比较。
在这项前瞻性、多中心观察性研究中,包括 25 名专门从事 CAM 治疗的初级保健医生,使用常规电子数据分析每位连续高血压患者的处方和诊断。使用单变量统计检验(卡方检验、Cochran-Armitage 趋势检验)进行数据分析。使用多变量逻辑回归确定与抗高血压药物相关的因素。
2005 年,共纳入 1320 名高血压患者,共 3278 张处方(平均年龄=64.2 岁(SD=14.5),63.5%为女性)。大多数患者接受常规降压单药治疗(n=838,63.5%)。β受体阻滞剂是最常用的单药治疗(30.7%),其次是血管紧张素转换酶抑制剂(24.0%)。联合治疗通常由两种降压药物组成,要么作为单独药物使用,要么作为复方制剂使用。最常见的联合治疗是利尿剂加血管紧张素转换酶抑制剂(双重治疗中 31.2%)。患者性别、年龄和合并症显著影响处方治疗。187 名患者(14.2%)接受了一种或多种 CAM 治疗方法,其中大多数与经典单药治疗联合使用(n=104)。男性(OR=0.66;95%CI:0.54-0.80)和糖尿病患者(OR=0.55;95%CI:0.42-0.0.73)、高胆固醇血症(OR=0.59;95%CI:0.47-0.75)、肥胖症(OR=0.74;95%CI:0.57-0.97)、中风(OR=0.54;95%CI:0.40-0.74)或既往心肌梗死(OR=0.37;95%CI:0.17-0.81)患者接受 CAM 治疗的可能性较低。
本研究中,CAM 医生开出的大多数降压治疗方案符合德国高血压学会的治疗指南。在接受某种形式 CAM 治疗的患者中,每七分之一的患者存在与指南不符的情况。